Td Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 142,396 shares of SRPT stock, worth $16.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

142,396

Previous 159,082 10.49%

Holding current value

$16.3 Million

Previous $25.1 Million 29.24%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$124.33 - $156.75 $2.07 Million - $2.62 Million	-16,686 Reduced 10.49%	142,396 $17.8 Million
Q2 2024 Aug 02, 2024	SELL	$113.33 - $163.85 $1.98 Million - $2.87 Million	-17,490 Reduced 9.91%	159,082 $25.1 Million
Q1 2024 May 08, 2024	SELL	$93.7 - $141.53 $2.86 Million - $4.32 Million	-30,540 Reduced 14.75%	176,572 $22.9 Million
Q4 2023 Feb 12, 2024	BUY	$67.31 - $124.76 $167,332 - $310,153	2,486 Added 1.21%	207,112 $20 Million
Q3 2023 Oct 27, 2023	BUY	$102.5 - $123.59 $16.6 Million - $20 Million	161,788 Added 377.67%	204,626 $24.8 Million
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $1.73 Million - $2.56 Million	-16,300 Reduced 27.56%	42,838 $4.91 Million
Q1 2023 May 10, 2023	BUY	$117.53 - $155.99 $2.22 Million - $2.95 Million	18,916 Added 47.03%	59,138 $8.15 Million
Q4 2022 Feb 06, 2023	SELL	$100.86 - $132.13 $104,390 - $136,754	-1,035 Reduced 2.51%	40,222 $5.21 Million
Q3 2022 Nov 07, 2022	SELL	$75.71 - $119.24 $225,464 - $355,096	-2,978 Reduced 6.73%	41,257 $4.52 Million
Q2 2022 Aug 04, 2022	BUY	$62.69 - $88.44 $106,573 - $150,348	1,700 Added 4.0%	44,235 $3.32 Million
Q1 2022 May 10, 2022	BUY	$63.15 - $90.42 $934,620 - $1.34 Million	14,800 Added 53.36%	42,535 $3.32 Million
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $977,286 - $1.22 Million	-14,086 Reduced 33.68%	27,735 $1.88 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $182,648 - $427,105	-2,528 Reduced 5.7%	41,821 $3.12 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $358,473 - $510,302	-2,855 Reduced 6.05%	44,349 $7.56 Million
Q3 2020 Nov 10, 2020	BUY	$127.12 - $172.34 $748,609 - $1.01 Million	5,889 Added 14.25%	47,204 $6.63 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $355,446 - $656,237	3,822 Added 10.19%	41,315 $6.62 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $3.42 Million - $5.46 Million	-41,500 Reduced 52.54%	37,493 $3.67 Million
Q4 2019 Feb 11, 2020	SELL	$76.53 - $135.58 $1.09 Million - $1.92 Million	-14,196 Reduced 15.23%	78,993 $10.2 Million
Q3 2019 Nov 07, 2019	BUY	$72.81 - $156.91 $73,392 - $158,165	1,008 Added 1.09%	93,189 $7.02 Million
Q2 2019 Aug 01, 2019	BUY	$112.21 - $151.95 $1.04 Million - $1.41 Million	9,300 Added 11.22%	92,181 $14 Million
Q1 2019 May 08, 2019	SELL	$106.67 - $151.68 $1.24 Million - $1.76 Million	-11,582 Reduced 12.26%	82,881 $9.88 Million
Q4 2018 Feb 01, 2019	BUY	$97.32 - $148.76 $661,776 - $1.01 Million	6,800 Added 7.76%	94,463 $10.3 Million
Q3 2018 Nov 01, 2018	SELL	$115.31 - $161.51 $788,374 - $1.1 Million	-6,837 Reduced 7.23%	87,663 $14.2 Million
Q2 2018 Jul 31, 2018	BUY	$71.74 - $153.69 $1.69 Million - $3.63 Million	23,600 Added 33.29%	94,500 $12.5 Million
Q1 2018 May 11, 2018	BUY	$54.02 - $82.27 $1.83 Million - $2.78 Million	33,800 Added 91.11%	70,900 $5.25 Million
Q4 2017 Feb 02, 2018	BUY	$47.64 - $56.75 $843,228 - $1 Million	17,700 Added 91.24%	37,100 $2.06 Million
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $693,161 - $914,710	19,400	19,400 $880,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Sarepta Therapeutics, Inc. Transaction History